Theory and practice : how much contrast for myelography?
A questionnaire sent to members of the British Society of Neuroradiologists revealed that the majority of practitioners will, when necessary, inject more than 3 g of iodine during myelography with iohexol or iopamidol. The 3 g limit recommended by the contrast medium manufacturers is not based upon...
Gespeichert in:
Veröffentlicht in: | Neuroradiology 1991-01, Vol.33 (5), p.411-413 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 413 |
---|---|
container_issue | 5 |
container_start_page | 411 |
container_title | Neuroradiology |
container_volume | 33 |
creator | HALPIN, S. F. S GUEST, P. J BYRNE, J. V |
description | A questionnaire sent to members of the British Society of Neuroradiologists revealed that the majority of practitioners will, when necessary, inject more than 3 g of iodine during myelography with iohexol or iopamidol. The 3 g limit recommended by the contrast medium manufacturers is not based upon scientific studies involving these media, and it is the experience of British neuroradiologists that larger amounts of modern contrast agents can be used without an increase in post myelography complications. There is, therefore, a need for a controlled trial to assess the question of the most appropriate dose of contrast medium in myelography. |
doi_str_mv | 10.1007/BF00598614 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72562853</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72562853</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-75340e301601627aa3d3f0047cac18b81634bd991fd39fbe31d939f0e330dca23</originalsourceid><addsrcrecordid>eNpFkEFLxDAQRoMo67p68S7kIB6E6iSTNo0X0cVVYcHLei5pmtqVtqlJi_TfW9lFYWAGvjff4RFyzuCGAcjbxxVArNKEiQMyZwJ5xBSHQzIH4GmESsAxOQnhEwBQopyRGZNCCcnmJN1U1vmR6ragndem3xpL72jlvmkzmIoa1_Zeh56WztNmtLX78LqrxvtTclTqOtiz_V6Q99XTZvkSrd-eX5cP68ggY30kYxRgEVgyDZdaY4ElgJBGG5bmKUtQ5IVSrCxQlblFVqjpmF4QCqM5LsjVrrfz7muwoc-abTC2rnVr3RAyyeOEpzFO4PUONN6F4G2ZdX7baD9mDLJfTdm_pgm-2LcOeWOLf3TnZcov97kORtel163Zhj8sBo5cKvwBE0JsnQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72562853</pqid></control><display><type>article</type><title>Theory and practice : how much contrast for myelography?</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>HALPIN, S. F. S ; GUEST, P. J ; BYRNE, J. V</creator><creatorcontrib>HALPIN, S. F. S ; GUEST, P. J ; BYRNE, J. V</creatorcontrib><description>A questionnaire sent to members of the British Society of Neuroradiologists revealed that the majority of practitioners will, when necessary, inject more than 3 g of iodine during myelography with iohexol or iopamidol. The 3 g limit recommended by the contrast medium manufacturers is not based upon scientific studies involving these media, and it is the experience of British neuroradiologists that larger amounts of modern contrast agents can be used without an increase in post myelography complications. There is, therefore, a need for a controlled trial to assess the question of the most appropriate dose of contrast medium in myelography.</description><identifier>ISSN: 0028-3940</identifier><identifier>EISSN: 1432-1920</identifier><identifier>DOI: 10.1007/BF00598614</identifier><identifier>PMID: 1749471</identifier><identifier>CODEN: NRDYAB</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Biological and medical sciences ; Contrast media. Radiopharmaceuticals ; England ; Humans ; Injections, Spinal ; Iohexol - administration & dosage ; Iopamidol - administration & dosage ; Medical sciences ; Myelography ; Pharmacology. Drug treatments ; Practice Patterns, Physicians ; Surveys and Questionnaires</subject><ispartof>Neuroradiology, 1991-01, Vol.33 (5), p.411-413</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-75340e301601627aa3d3f0047cac18b81634bd991fd39fbe31d939f0e330dca23</citedby><cites>FETCH-LOGICAL-c311t-75340e301601627aa3d3f0047cac18b81634bd991fd39fbe31d939f0e330dca23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5023279$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1749471$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HALPIN, S. F. S</creatorcontrib><creatorcontrib>GUEST, P. J</creatorcontrib><creatorcontrib>BYRNE, J. V</creatorcontrib><title>Theory and practice : how much contrast for myelography?</title><title>Neuroradiology</title><addtitle>Neuroradiology</addtitle><description>A questionnaire sent to members of the British Society of Neuroradiologists revealed that the majority of practitioners will, when necessary, inject more than 3 g of iodine during myelography with iohexol or iopamidol. The 3 g limit recommended by the contrast medium manufacturers is not based upon scientific studies involving these media, and it is the experience of British neuroradiologists that larger amounts of modern contrast agents can be used without an increase in post myelography complications. There is, therefore, a need for a controlled trial to assess the question of the most appropriate dose of contrast medium in myelography.</description><subject>Biological and medical sciences</subject><subject>Contrast media. Radiopharmaceuticals</subject><subject>England</subject><subject>Humans</subject><subject>Injections, Spinal</subject><subject>Iohexol - administration & dosage</subject><subject>Iopamidol - administration & dosage</subject><subject>Medical sciences</subject><subject>Myelography</subject><subject>Pharmacology. Drug treatments</subject><subject>Practice Patterns, Physicians</subject><subject>Surveys and Questionnaires</subject><issn>0028-3940</issn><issn>1432-1920</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEFLxDAQRoMo67p68S7kIB6E6iSTNo0X0cVVYcHLei5pmtqVtqlJi_TfW9lFYWAGvjff4RFyzuCGAcjbxxVArNKEiQMyZwJ5xBSHQzIH4GmESsAxOQnhEwBQopyRGZNCCcnmJN1U1vmR6ragndem3xpL72jlvmkzmIoa1_Zeh56WztNmtLX78LqrxvtTclTqOtiz_V6Q99XTZvkSrd-eX5cP68ggY30kYxRgEVgyDZdaY4ElgJBGG5bmKUtQ5IVSrCxQlblFVqjpmF4QCqM5LsjVrrfz7muwoc-abTC2rnVr3RAyyeOEpzFO4PUONN6F4G2ZdX7baD9mDLJfTdm_pgm-2LcOeWOLf3TnZcov97kORtel163Zhj8sBo5cKvwBE0JsnQ</recordid><startdate>19910101</startdate><enddate>19910101</enddate><creator>HALPIN, S. F. S</creator><creator>GUEST, P. J</creator><creator>BYRNE, J. V</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19910101</creationdate><title>Theory and practice : how much contrast for myelography?</title><author>HALPIN, S. F. S ; GUEST, P. J ; BYRNE, J. V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-75340e301601627aa3d3f0047cac18b81634bd991fd39fbe31d939f0e330dca23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Biological and medical sciences</topic><topic>Contrast media. Radiopharmaceuticals</topic><topic>England</topic><topic>Humans</topic><topic>Injections, Spinal</topic><topic>Iohexol - administration & dosage</topic><topic>Iopamidol - administration & dosage</topic><topic>Medical sciences</topic><topic>Myelography</topic><topic>Pharmacology. Drug treatments</topic><topic>Practice Patterns, Physicians</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HALPIN, S. F. S</creatorcontrib><creatorcontrib>GUEST, P. J</creatorcontrib><creatorcontrib>BYRNE, J. V</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroradiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HALPIN, S. F. S</au><au>GUEST, P. J</au><au>BYRNE, J. V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Theory and practice : how much contrast for myelography?</atitle><jtitle>Neuroradiology</jtitle><addtitle>Neuroradiology</addtitle><date>1991-01-01</date><risdate>1991</risdate><volume>33</volume><issue>5</issue><spage>411</spage><epage>413</epage><pages>411-413</pages><issn>0028-3940</issn><eissn>1432-1920</eissn><coden>NRDYAB</coden><abstract>A questionnaire sent to members of the British Society of Neuroradiologists revealed that the majority of practitioners will, when necessary, inject more than 3 g of iodine during myelography with iohexol or iopamidol. The 3 g limit recommended by the contrast medium manufacturers is not based upon scientific studies involving these media, and it is the experience of British neuroradiologists that larger amounts of modern contrast agents can be used without an increase in post myelography complications. There is, therefore, a need for a controlled trial to assess the question of the most appropriate dose of contrast medium in myelography.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>1749471</pmid><doi>10.1007/BF00598614</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-3940 |
ispartof | Neuroradiology, 1991-01, Vol.33 (5), p.411-413 |
issn | 0028-3940 1432-1920 |
language | eng |
recordid | cdi_proquest_miscellaneous_72562853 |
source | MEDLINE; SpringerLink Journals |
subjects | Biological and medical sciences Contrast media. Radiopharmaceuticals England Humans Injections, Spinal Iohexol - administration & dosage Iopamidol - administration & dosage Medical sciences Myelography Pharmacology. Drug treatments Practice Patterns, Physicians Surveys and Questionnaires |
title | Theory and practice : how much contrast for myelography? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T16%3A37%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Theory%20and%20practice%20:%20how%20much%20contrast%20for%20myelography?&rft.jtitle=Neuroradiology&rft.au=HALPIN,%20S.%20F.%20S&rft.date=1991-01-01&rft.volume=33&rft.issue=5&rft.spage=411&rft.epage=413&rft.pages=411-413&rft.issn=0028-3940&rft.eissn=1432-1920&rft.coden=NRDYAB&rft_id=info:doi/10.1007/BF00598614&rft_dat=%3Cproquest_cross%3E72562853%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72562853&rft_id=info:pmid/1749471&rfr_iscdi=true |